John Baldoni, ex-GSK R&D Leader, Joins BioSymetrics as Strategic Advisor
/PRNewswire/ -- BioSymetrics, a phenomics-driven AI drug discovery company, today announced that John Baldoni will join its strategic advisory board. John is a...
Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- BioSymetrics, a phenomics-driven AI drug discovery company, today announced that John Baldoni will join its strategic advisory board. John is a...
Aptabio's Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney...
/PRNewswire/ -- Sinoveda is a Canadian-based health-science brand that is blazing an innovative trail toward the future of healthcare. The company has...
Synaffix obtains exclusive rights to the CliCr technology, to combine with its proprietary ADC platform technology CliCr further expands the repertoire of payloads suitable for conjugation by
/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...